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HIGHLIGHTS 
• High blood pressure is well recognized as a major cause of morbidity and mortality. 
• A strong association between obesity and the risk of hypertension has been reported. 
• BAI has been recently proposed as a new method to estimate percentage of body fat. 
• BAI is revealed as an alternative to traditional body adiposity measures in order to 
predict incident hypertension in adults. 
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Abstract 
Background and Aim: The body adiposity index (BAI) has been recently proposed as a new 
method to estimate the percentage of body fat. The association between BAI and hypertension 
risk has not been investigated yet. The aim of our study was to evaluate the ability of BAI to 
predict hypertension in males and females compared with traditional body adiposity 
measures. 
Methods and Results: The present follow-up analysis comprised 10 309 individuals (2259 
females) free of hypertension from the Aerobics Center Longitudinal Study, who completed a 
baseline examination during 1988-2003. Body adiposity measures included BAI, body mass 
index (BMI), waist circumference, hip circumference, percentage of body fat and waist to hip 
ratio (WHR). Incident hypertension was ascertained from responses to mail-back surveys 
between 1990 and 2004. During an average of 9.1 years of follow-up, 872 subjects (107 
females) became hypertensive. Hazard ratios (HRs) and 95% confidence intervals (95% CI) 
showed that males in the highest categories of all body adiposity measures showed a higher 
incident risk of hypertension (HRs ranged from 1.37 to 2.09). Females showed a higher 
incident risk of hypertension only in the highest categories of BAI, BMI and WHR (HRs 
ranged from 1.84 to 3.36). 
Conclusion: Our results suggest that in order to predict incident hypertension BAI could be 
considered as an alternative to traditional body adiposity measures. 
 
Key words 
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INTRODUCTION 
Hypertension, defined as a persistent resting systolic/diastolic blood pressure ≥140/90 mmHg, 
has reached epidemic proportions worldwide. In fact, more than a quarter of the world’s adult 
population had hypertension in the year 2000, and this proportion is estimated to increase to 
around 30% in the year 2025 [1]. Currently, high blood pressure is well recognized as a major 
cause of morbidity and mortality [2]. 
Overweight and obesity may also increase risk of co-morbidities, which can lead to further 
morbidity and mortality [3]. In recent years, there have been an increased number of studies 
showing the strong association between obesity and the risk of hypertension [4, 5]. 
Body mass index (BMI), waist circumference and waist to hip ratio (WHR) are strong 
predictors of obesity-related morbidity and mortality [6, 7]. Despite their limitations, both are 
commonly used as adiposity measures in large epidemiological studies where the use of more 
accurate methods are not available due to complexity and/or cost [8]. 
Recently, Bergman et al. [9], proposed the body adiposity index (BAI) as a new method to 
estimate percentage of body fat (%BF) without requiring a measure of body weight. Several 
validation studies have analyzed the correlation between BAI and %BF estimated by accurate 
methods such as DXA [9-13], magnetic resonance [14], or computed tomography [11]. 
Moreover, other studies have examined the association of BAI with traditional and novel 
cardiovascular disease (CVD) risk factors [11, 14-19]. 
In our best knowledge, the association between BAI and hypertension risk has not been 
investigated. Therefore, the aim of our study was to compare BAI and established body 
adiposity measures with respect to their ability to predict hypertension risk in a sample of men 
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and women participating in the Aerobics Center Longitudinal Study (ACLS). Furthermore, 
we analyzed the cross-sectional association of BAI and established body adiposity measures 
with traditional CVD risk factors. 
METHODS 
Subjects 
Data for this report are from the ACLS, a prospective epidemiological study of individuals 
who received extensive preventive medical examinations at the Cooper Clinic in Dallas, 
Texas, USA. Details of the study design and the characteristics of the cohort have been 
reported previously [20]. Study participants were referred by their employers or physicians, or 
were self-referred. They were mainly Caucasian, relatively well-educated, and from middle-
to-upper socioeconomic strata. After receiving complete information about the aims and 
methods of the study, all participants gave written informed consent for the examinations and 
follow-up. The study protocol was reviewed and approved annually by Cooper Institute’s 
Institutional Review Board. 
For the present analysis we included all individuals who received a baseline medical 
examination between 1988 and 2003, responded to at least one mail-back health survey 
during follow-up, and with valid data for all the body adiposity measures. Among 12 303 
participants aged ≥20 years at baseline, we excluded 53 reporting myocardial infarction or 
stroke; 52 reporting cancer; 127 with BMI <18.5 kg/m2; 887 with resting systolic/diastolic 
blood pressure ≥140/90 mmHg or physician diagnosis of hypertension; and 633 not reaching 
85% of their age-predicted maximal heart rate (220 minus age in years) on a treadmill test. In 
addition, 242 subjects with <1 year of follow-up were excluded to minimize potential bias due 
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to undetected hypertension. The final sample size for the present report comprised 8050 males 
and 2259 females for analyses of incident hypertension. 
Clinical Examination 
Clinical examinations were completed after 12h fast and have been described in detail 
elsewhere [20]. Briefly, weight, height, waist and hip circumferences were measured with a 
standard clinical scale, stadiometer and plastic tape according to ACLS standard procedures. 
BMI was computed as weight in kilograms divided by height in meters squared (kg/m2), and 
WHR as waist circumference in centimeters divided by hip circumference in centimeters. BAI 
was calculated according to Bergman et al. [9] equation ((hip circumference in cm/height in 
meters1.5)-18). %BF was assessed using hydrostatic weighing, the sum of seven skinfold 
measures, or both methods, following standardized protocols [21]. Participants were classified 
according to adiposity categories using standard clinical definitions for BMI (18.5 to 24.9 as 
normal weight; 25 to 29.9 as overweight; ≥30 as obese) and waist circumference (≥102 cm for 
males and ≥88 cm for females as having central obesity) [22]. Since there is not a specific 
agreement about obesity cut-off points for BAI, hip circumference, %BF and WHR, specific 
tertiles from this population were used. 
Resting blood pressure was measured by trained technicians using auscultatory methods in the 
seated position and was recorded as the first and fifth Korotkoff sounds after ≥5 minutes of 
sitting quietly using mercury sphygmomanometers. Two readings separated by 2 minutes 
were averaged. If the first 2 readings differed by >5 mmHg, additional readings were obtained 
and averaged. Electrocardiogram (ECG) was measured at rest and with exercise, and 
abnormal ECG responses included rhythm and conduction disturbances and ischemic ST-T 
wave abnormalities. Serum samples were analyzed for glucose and total cholesterol using 
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standardized automated bioassays at the Cooper Clinic Laboratory. Diabetes mellitus was 
defined as fasting plasma glucose concentration of ≥126 mg/dL, a history of physician 
diagnosis, or insulin use. Hypercholesterolemia was defined as total cholesterol of ≥240 
mg/dL or a history of physician diagnosis. 
Physical activity, cigarette smoking, alcohol intake, and parental history of CVD and 
hypertension were assessed by self-report on a medical history questionnaire. Physically 
inactive was defined as reporting no leisure-time physical activity in the 3 months before the 
baseline examination. Smoking status was classified as current smoker or not. Heavy alcohol 
consumption was defined as >14 units/week for males and >7 units/week for females. One 
unit of alcohol intake was defined as a bottle or can of beer [355 mL (12 oz)], a glass of wine 
[148 mL (5 oz)], or 44 mL (1.5 oz) of hard liquor. Parental history of CVD was defined as the 
occurrence of heart attacks, coronary disease, angioplasty, or stroke before the age of 50 years 
in either father or mother. Parental history of hypertension was defined as a history of 
physician diagnosis in either father or mother. 
Cardiorespiratory fitness (CRF) was quantified as the total time of a symptom-limited 
maximal treadmill exercise test, using a modified Balke protocol [23]. To standardize exercise 
performance, we estimated maximal metabolic equivalents (METs; 1 MET = 3.5 mL O2 
uptake per kilogram per minute) from the final treadmill speed and grade [24]. 
Incident hypertension 
Incident hypertension was ascertained from responses to mail-back surveys in 1990, 1995, 
1999, and 2004. A case-finding question for physician-diagnosed illness was used to identify 
cases of hypertension. Participants were asked if a physician had ever told them they had 
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hypertension. If yes, respondents were asked to report the year of diagnosis. In participants 
who completed multiple surveys, the first survey in which hypertension was reported was 
used in the analyses. This method of case ascertainment has been used in other large, 
population-based epidemiologic studies of hypertension [23]. The aggregate survey response 
rate across all survey periods in the ACLS is about 65%, but it has been investigated in ACLS 
and does not present a major source of bias [25]. Sensitivity and specificity of self-reported, 
physician-diagnosed hypertension was verified in this cohort and observed 98% and 99%, 
respectively [23]. 
Statistical analysis 
Descriptive analyses summarized baseline characteristics of the participants based on sex-
specific BAI tertiles. Differences between groups were tested using analysis of the variance 
(ANOVA) for continuous variables and chi-square tests for categorical variables. Partial 
correlations between body adiposity measures were calculated after controlling for age and 
baseline examination year. We also examined the association of body adiposity measures with 
CVD risk factors using linear regression, controlling for age, baseline examination year, and 
survey response pattern. Cox proportional hazards regression analysis was used to estimate 
hazard ratios (HRs), and associated 95% confidence intervals (95% CIs) for incidence of 
hypertension, according to adiposity exposure categories from BAI, BMI, waist and hip 
circumferences, %BF and WHR. The lowest adiposity category was ever used as the 
reference category. To allow comparisons between adiposity measures, the results were also 
presented as standardized HRs by transforming each variable to have a mean of 0 and SD of 
1. Indicator variables (yes/no) were constructed for each survey period to account for 
differences in survey response patterns in order to reduce the influence of ascertainment bias. 
In multivariable analyses, model 1 accounted for age, baseline examination year, and survey 
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response pattern. Model 2 included physical activity, smoking habit, alcohol intake, abnormal 
ECG, hypercholesterolemia, diabetes, and parental history of CVD and hypertension as 
confounders. Model 3 additionally adjusted for CRF. The proportional hazards assumption 
was examined by comparing the cumulative hazard plots grouped on exposure and no 
appreciable violations were noted. All the analyses were performed using PASW statistical 
package version 18.0 (SPSS Inc, Chicago, IL), considering P<0.05 as statistically significant. 
RESULTS 
During an average follow-up of 9.1 years, 872 subjects (107 females) became hypertensive. 
The characteristics of the study population by sex-specific BAI tertiles are shown in Table 1. 
Except for current smokers and parental history of hypertension in males, and diabetes, 
parental history of CVD and hypertension in females, all variables presented significant 
differences across BAI tertiles. 
Table 1 here 
Partial correlations examining the associations between body adiposity measures after 
controlling for age and examination year are shown in Table 2. All body adiposity measures 
were positively correlated each other (P≤0.001). The highest correlation values for BAI were 
observed with BMI in males (r=0.787) and with hip circumference in females (r=0.832). 
Table 2 here 
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According to Table 3, all body adiposity measures were significantly associated with CVD 
risk factors (all P≤0.001). BAI showed the lowest correlation values with fasting blood 
glucose when it was compared with the other body adiposity measures in both males and 
females. BAI associations with total cholesterol, fasting blood glucose and CRF were stronger 
among males, while BAI associations with systolic and diastolic blood pressure were stronger 
among females. Except for the WHR in females, all body adiposity measures showed the 
strongest association with CRF among all the risk factors in males and females. 
Table 3 here 
Table 4 shows HRs for incidence of hypertension according to 3 different sets of confounders 
(model 1, model 2 and model 3). In the fully-adjusted model, males in all the highest 
categories of body adiposity measures showed a higher incidence risk of hypertension (HRs 
ranged from 1.37 to 2.09). Females showed a higher incidence risk of hypertension in the 
highest categories of BAI, BMI and WHR (HRs 1.84 and 3.36, respectively). Per 1 SD 
increase, HRs were similar between all the body adiposity measures in males (ranging from 
1.15 to 1.29) and between BAI, BMI and WHR in females (ranging from 1.25 to 1.31). 
Table 4 here 
DISCUSSION 
The results of this report suggest that in order to predict incident hypertension among 
participants enrolled in the ACLS between 1988 and 2003, BAI could be considered as an 
alternative to established body adiposity measures. 
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The BAI has recently been proposed by Bergman et al. [9] to provide valid direct estimates of 
%BF. In our study, the mean intra-individual difference between BAI and %BF ranged from 
2.5 to 3.9% in males, and from 1.8 to 2.0% in females across BAI tertiles. Moreover, in 
general BAI showed slightly lower correlation values with %BF than other body adiposity 
measures. Similar results have been found in some BAI validation studies when correlation 
analyses were sex-stratified, indicating that calculation of BAI results in inaccurate estimation 
of %BF [10, 12-14]. 
Previous studies showed a strong association of established body adiposity measures with 
CVD risk factors [6, 26, 27], but the association with BAI seemed to be weaker [11, 14-19]. 
Our results concur with previous ones reporting significant associations between all adiposity 
measures and CVD risk factors (e.g. cholesterol, glucose, blood pressure, and CRF). 
However, in general BAI showed weaker associations than established body adiposity 
measures, indicating that in our sample BAI did not provide a meaningful alternative to 
established adiposity measures as a CVD risk indicator. 
Due to the limitations of established body adiposity measures, the development of other 
simple, accurate, and inexpensive methods to assess %BF are needed for clinical and 
epidemiological research. Those methods need to be valid to assess body composition and to 
derive some insight into health risks associated with obesity. We tested if the new BAI 
proposed by Bergman et al. [9] may be a valid method to assess body composition by 
analyzing its ability to predict incidence risk of hypertension in adults. Such data may be 
essential to establish the validity of BAI for screening agent, as well as to be used in research 
protocols were a high number of participants are involved. 
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In our best knowledge, no previous studies have analyzed the ability of BAI to predict the risk 
of incident hypertension. Combined with previous results, our study shows that BAI may not 
be a better indicator of body fat [10, 12-14] or CVD risk [11, 14-19] than the established body 
adiposity measures. Nevertheless, in order to predict incident hypertension BAI could be 
considered as an alternative to established body adiposity measures, particularly when a 
weight measurement is not available. The middle tertile of BAI only identified higher risk of 
hypertension in males, thus showing lower discrimination accuracy in females. These gender 
differences could indicate that BAI is an approach of %BF, but does not reflect fat 
distribution, which is known to have large differences between males and females (android 
vs. gynoid obesity). 
The results of the present analysis should be interpreted with caution due to several 
limitations. First, since our study mainly included Caucasian, well-educated men from 
middle-to-upper socioeconomic strata, the results may not extend to other populations. 
However, the homogeneity of the sample enhances internal validity of our findings because it 
reduces the likelihood of confounding by these characteristics. Second, %BF was estimated 
from skinfold measures or hydrostatic weighing, each of which have well known 
methodological limitations. Third, as we only have baseline data of exposures, we do not 
know whether changes in any of these variables occurred during follow-up and how this 
might have influenced the results. Fourth, we could not take into account dietary habits (e.g. 
sodium intake) or medication use to control for these potential confounders in the analysis. 
Finally, because of the widespread geographical distribution of participants, we were unable 
to verify all reported hypertension events. However, it appears that an acceptable level of 
agreement exists between participants’ self-reported histories and their medical records based 
on a validation study [23]. Despite these limitations, the main strengths of this study include 
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the large, well-characterized cohort, the prospective design of the study, the relatively long 
follow-up period, and the extensive baseline examination that reduced the possible bias of 
subclinical disease. 
In conclusion, the findings of the present analyses add information about the newly proposed 
BAI, suggesting that in order to predict incident hypertension BAI could be considered as an 
alternative to established body adiposity measures. Also, our results show that the association 
of BAI with CVD risk factors is slightly weaker than for traditional body adiposity measures. 
Further epidemiological studies examining the utility of BAI for other populations are still 
needed for a better understanding of the validity of this new index. 
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Table 1. Baseline characteristics of participants by sex-specific body adiposity index (BAI) tertiles. 
 
BAI  (tertliles) 
 
Males  Females 
Characteristic Lower (n=2677) 
Middle 
(n=2693) 
Upper 
(n=2680) P value
a
  
Lower 
(n=749) 
Middle 
(n=755) 
Upper 
(n=755) P value
a
 
Age (years) 46.1 (9.7) 47.9 (9.4) 48.8 (9.4) <0.001  45.2 (8.8) 48.1 (9.5) 49.2 (9.7) <0.001 
Body mass index (kg/m2) 23.6 (1.8) 25.6 (2.0) 28.7 (3.2) <0.001  20.9 (1.7) 22.6 (1.9) 26.6 (4.0) <0.001 
Waist circumference (cm) 86.6 (6.9) 91.6 (7.2) 98.6 (9.4) <0.001  68.7 (8.0) 71.5 (6.1) 79.6 (10.1) <0.001 
Hip circumference (cm) 96.6 (4.9) 100.3 (4.8) 106.0 (6.9) <0.001  89.3 (6.1) 95.4 (4.7) 104.6 (8.3) <0.001 
BAI (%) 21.1 (1.3) 23.9 (0.7) 27.4 (2.2) <0.001  23.3 (2.3) 27.3 (1.0) 32.5 (3.4) <0.001 
%BF 17.2 (5.0) 20.6 (4.7) 24.9 (5.2) <0.001  21.5 (5.1) 25.3 (5.1) 30.7 (5.5) <0.001 
WHR 0.9(0.1) 0.9 (0.1) 0.9 (0.1) >0.001  0.8 (0.1) 0.8 (0.1) 0.8 (0.1) <0.001 
Treadmill time (min) 21.9 (4.4) 19.9 (4.2) 17.2 (4.2) <0.001  16.9 (4.4) 14.8 (3.7) 12.3 (3.7) <0.001 
Maximal metabolic equivalents (MET) 13.6 (2.4) 12.6 (2.1) 11.3 (2.0) <0.001  11.2 (2.1) 10.2 (1.7) 9.0 (1.7) <0.001 
Total cholesterol (mg/dL) 194.3 (36.0) 202.9 (37.0) 208.6 (38.3) <0.001  187.8 (31.9) 196.4 (33.8) 202.0 (33.1) <0.001 
Fasting blood glucose (mg/dL) 97.1 (14.1) 98.2 (12.2) 100.9 (17.2) <0.001  92.7 (14.8) 93.0 (8.3) 95.0 (18.4) 0.003 
Blood pressure (mmHg)          
Systolic 116.6 (9.5) 117.4 (9.1) 118.4 (9.2) <0.001  108.4 (10.7) 110.9 (10.9) 113.6 (11.0) <0.001 
Diastolic 77.2 (6.8) 78.0 (6.4) 79.0 (6.2) <0.001  72.9 (7.5) 74.5 (7.1) 75.9 (7.2) <0.001 
Physically inactive, No (%)b 402 (15.0) 509 (18.9) 665 (24.8) <0.001  95 (12.7) 114 (15.1) 153 (20.3) <0.001 
Current smokers, No (%) 283 (10.6) 299 (11.1) 316 (11.8) 0.364  36 (4.8) 44 (5.8) 23 (3.0) 0.032 
Heavy drinkers, No (%)c 199 (7.4) 252 (9.4) 257 (9.6) 0.009  143 (19.1) 133 (17.6) 105 (13.9) 0.022 
Baseline medical conditions, No (%)          
Abnormal ECGd 195 (7.3) 238 (8.8) 261 (9.7) 0.005  55 (7.3) 63 (8.3) 85 (11.3) 0.022 
Hypercholesterolemiae 542 (20.2) 725 (26.9) 865 (32.3) <0.001  118 (15.8) 178 (23.6) 211 (27.9) <0.001 
Diabetes mellitusf 63 (2.4) 68 (2.5) 127 (4.7) <0.001  22 (2.9) 27 (3.6) 33 (4.4) 0.330 
Parental history of CVD, No (%) 501 (18.7) 560 (20.8) 615 (22.9) 0.001  170 (22.7) 196 (26.0) 201 (26.6) 0.171 
Parental history of hypertension, No (%) 623 (23.3) 689 (25.6) 690 (25.7) 0.064  287 (38.3) 310 (41.1) 322 (42.6) 0.224 
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Values are means (standard deviations) or numbers (percentage). %BF indicates percentage of body fat; WHR, waist to hip ratio; CVD, cardiovascular 
disease; MET: metabolic equivalents. 
a Analysis of the variance (ANOVA) for continuous variables and chi-square tests for categorical variables. 
b Defined as reporting no physical activity during leisure time in the 3 months before the examination. 
c Defined as >14 and >7 drinks/week for males and females, respectively. 
d Abnormal resting or exercise electrocardiogram. 
e Defined as total cholesterol ≥240 mg/dL or previous physician diagnosed hypercholesterolemia. 
f Defined as fasting blood glucose ≥126 mg/dL, previous physician diagnosed diabetes or use of insulin. 
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Table 2. Partial correlations examining the association between body adiposity measures after controlling for age and 
baseline examination year. 
 Males  Females 
 BAI BMI Waist Hip %BF WHR  BAI BMI Waist Hip %BF WHR 
BAI -       -      
BMI 0.787 -      0.780 -     
Waist 0.616 0.864 -     0.519 0.819 -    
Hip 0.687 0.804 0.831 -    0.832 0.791 0.658 -   
%BF 0.607 0.694 0.740 0.669 -   0.638 0.724 0.620 0.660 -  
WHR 0.255 0.548 0.754 0.264 0.500 -  -0.172 0.260 0.629 -0.156 0.143 - 
BAI indicates body adiposity index; BMI, body mass index; waist, waist circumference; hip, hip circumference; 
%BF, percentage of total body fat; WHR, waist to hip ratio. 
All correlations were statistically significant at P ≤ 0.001 
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Table 3. Standardized regression coefficients examining the association of body adiposity index (BAI), body mass index 
(BMI), waist circumference, hip circumference, percentage of body fat (%BF), and waist to hip ratio (WHR) with 
cardiovascular disease risk factors. 
 Body Adiposity Index (BAI) 
 Males  Females 
 R2 β  r R2 change  R2 β  r R2 change 
Total cholesterol 0.054 0.162 0.170 0.026  0.137 0.117 0.163 0.013 
Fasting blood glucose 0.027 0.114 0.127 0.013  0.043 0.084 0.086 0.007 
Systolic blood pressure 0.022 0.085 0.099 0.007  0.122 0.171 0.212 0.028 
Diastolic blood pressure 0.023 0.122 0.128 0.014  0.061 0.154 0.180 0.023 
Cardiorespiratory fitnessa 0.321 -0.400 -0.450 0.157  0.353 -0.401 -0.460 0.155 
 Body Mass Index (BMI) 
Total cholesterol 0.052 0.157 0.143 0.024  0.147 0.156 0.186 0.024 
Fasting blood glucose 0.040 0.163 0.164 0.026  0.049 0.113 0.119 0.012 
Systolic blood pressure 0.033 0.136 0.145 0.018  0.143 0.224 0.250 0.049 
Diastolic blood pressure 0.042 0.187 0.194 0.034  0.080 0.207 0.222 0.042 
Cardiorespiratory fitnessa 0.348 -0.437 -0.467 0.184  0.359 -0.404 -0.447 0.160 
 Waist Circumference 
Total cholesterol 0.053 0.158 0.174 0.024  0.147 0.155 0.199 0.024 
Fasting blood glucose 0.045 0.179 0.194 0.031  0.058 0.148 0.156 0.021 
Systolic blood pressure 0.028 0.114 0.127 0.013  0.132 0.199 0.237 0.039 
Diastolic blood pressure 0.039 0.177 0.179 0.030  0.080 0.208 0.229 0.042 
Cardiorespiratory fitnessa 0.395 -0.488 -0.541 0.231  0.320 -0.353 -0.411 0.121 
All analyses adjusted for age and baseline examination year. 
All P values were significant at ≤ 0.001. 
a
 Maximal metabolic equivalents, MET. 
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Table 3. Continued. 
 Hip circumference 
 Males  Females 
 R2 β  r R2 change  R2 β  r R2 change 
Total cholesterol 0.038 0.102 0.094 0.010  0.132 0.093 0.120 0.008 
Fasting blood glucose 0.029 0.124 0.128 0.015  0.046 0.100 0.091 0.010 
Systolic blood pressure 0.026 0.106 0.115 0.011  0.123 0.174 0.198 0.029 
Diastolic blood pressure 0.033 0.160 0.167 0.025  0.068 0.177 0.195 0.030 
Cardiorespiratory fitnessa 0.315 -0.392 -0.423 0.150  0.345 -0.389 -0.426 0.147 
 Percentage of body fat (%BF) 
Total cholesterol 0.059 0.185 0.188 0.031  0.152 0.173 0.237 0.028 
Fasting blood glucose 0.030 0.131 0.152 0.016  0.041 0.068 0.101 0.004 
Systolic blood pressure 0.019 0.066 0.094 0.004  0.112 0.139 0.193 0.018 
Diastolic blood pressure 0.029 0.151 0.159 0.021  0.063 0.164 0.186 0.025 
Cardiorespiratory fitnessa 0.463 -0.572 -0.641 0.298  0.440 -0.505 -0.574 0.241 
 Waist to hip ratio (WHR) 
Total cholesterol 0.052 0.159 0.189 0.024  0.133 0.098 0.129 0.010 
Fasting blood glucose 0.038 0.159 0.176 0.024  0.043 0.082 0.100 0.007 
Systolic blood pressure 0.020 0.071 0.082 0.005  0.099 0.072 0.097 0.005 
Diastolic blood pressure 0.022 0.121 0.114 0.014  0.045 0.083 0.093 0.007 
Cardiorespiratory fitnessa 0.306 -0.388 -0.437 0.141  0.203 -0.070 -0.107 0.005 
All analyses adjusted for age and baseline examination year. 
All P values were significant at ≤ 0.001. 
a
 Maximal metabolic equivalents, MET. 
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Table 4. Hazard ratios for incidence of hypertension according to different measures of adiposity. 
 Hazard ratio (95% CI) 
 Males  Females 
 
Model 1 a Model 2 b Model 3 c  Model 1 a Model 2 b Model 3 c 
BAI        
Low 1.00 (Referent) 1.00 (Referent) 1.00 (Referent)  1.00 (Referent) 1.00 (Referent) 1.00 (Referent) 
Middle 1.47 (1.22 – 1.78) 1.45 (1.20 – 1.75) 1.39 (1.15 – 1.68)  1.15 (0.67 – 1.95) 1.13 (0.66 – 1.92) 1.09 (0.64 – 1.87) 
Upper 1.92 (1.60 – 2.31) 1.86 (1.55 – 2.23) 1.68 (1.38 – 2.04)  2.01 (1.24 – 3.27) 1.99 (1.22 – 3.26) 1.84 (1.10 – 3.08) 
Per 1 SD increase 1.33 (1.24 – 1.42) 1.31 (1.22 – 1.40) 1.26 (1.16 – 1.35)  1.32 (1.10 – 1.58) 1.32 (1.10 – 1.59) 1.28 (1.04 – 1.56) 
BMI        
18.5 - 24.9 kg/m2 1.00 (Referent) 1.00 (Referent) 1.00 (Referent)  1.00 (Referent) 1.00 (Referent) 1.00 (Referent) 
25.0 - 29.9 kg/m2 1.56 (1.34 – 1.83) 1.53 (1.30 – 1.79) 1.45 (1.23 – 1.71)  1.73 (1.11 – 2.69) 1.67 (1.07 – 2.62) 1.61 (1.01 – 2.58) 
≥ 30.0 kg/m2 2.53 (2.02 – 3.17) 2.37 (1.88 – 2.98) 2.09 (1.63 – 2.70)  3.62 (1.97 – 6.65) 3.59 (1.92 – 6.72) 3.36 (1.71 – 6.60) 
Per 1 SD increase 1.35 (1.26 – 1.44) 1.32 (1.24 – 1.42) 1.28 (1.18 – 1.38)  1.34 (1.14 – 1.57) 1.35 (1.14 – 1.59) 1.31 (1.08 – 1.58) 
Waist circumferenced        
Low  1.00 (Referent) 1.00 (Referent) 1.00 (Referent)  1.00 (Referent) 1.00 (Referent) 1.00 (Referent) 
High 1.80 (1.51 – 2.14) 1.70 (1.42 – 2.03) 1.49 (1.23 – 1.81)  1.98 (1.13 – 3.45) 1.92 (1.09 – 3.39) 1.72 (0.95 – 3.09) 
Per 1 SD increase 1.36 (1.27 – 1.45) 1.33 (1.24 – 1.43) 1.29 (1.19 – 1.40)  1.31 (1.11 – 1.55) 1.30 (1.09 – 1.54) 1.25 (1.04 – 1.51) 
BAI indicates body adiposity index; BMI, body mass index; SD, standard deviation; %BF, percentage of body fat. 
a
 Adjusted for age, baseline examination year, and survey response pattern. 
b
 Adjusted for model 1 plus physical activity (active or inactive), smoking (current smoker or not), alcohol intake (> 14 drinks/week ♂ / > 7 
drinks/week ♀ or not), abnormal electrocardiogram, hypercholesterolemia and diabetes (present or not for each), and parental history of CVD 
and hypertension. 
c
 Adjusted for model 2 plus cardiorespiratory fitness (treadmill test duration in minutes). 
d
 Low waist circumference indicates < 102 cm ♂ and < 88 cm ♀; High waist circumference, ≥ 102 cm ♂ and  ≥ 88 cm ♀. 
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Table 4. Continued. 
 Hazard ratio (95% CI) 
 Males  Females 
 
Model 1 a Model 2 b Model 3 c  Model 1 a Model 2 b Model 3 c 
Hip circumference        
Low 1.00 (Referent) 1.00 (Referent) 1.00 (Referent)  1.00 (Referent) 1.00 (Referent) 1.00 (Referent) 
Middle 1.21 (1.01 – 1.46) 1.20 (0.99 – 1.44) 1.14 (0.95 – 1.38)  1.15 (0.71 – 1.87) 1.12 (0.68 – 1.82) 1.06 (0.65 – 1.74) 
Upper 1.70 (1.42 – 2.02) 1.64 (1.37 – 1.96) 1.46 (1.21 – 1.77)  1.39 (0.87 – 2.23) 1.31 (0.81 – 2.11) 1.16 (0.70 – 1.90) 
Per 1 SD increase 1.28 (1.19 – 1.37) 1.26 (1.17 – 1.35) 1.20 (1.11 – 1.29)  1.22 (1.01 – 1.47) 1.20 (0.99 – 1.45) 1.14 (0.92 – 1.40) 
%BF        
Low 1.00 (Referent) 1.00 (Referent) 1.00 (Referent)  1.00 (Referent) 1.00 (Referent) 1.00 (Referent) 
Middle 1.23 (1.02 – 1.48) 1.19 (0.99 – 1.44) 1.10 (0.90 – 1.33)  1.19 (0.71 – 1.97) 1.14 (0.68 – 1.91) 1.04 (0.62 – 1.76) 
Upper 1.69 (1.41 – 2.02) 1.60 (1.33 – 1.93) 1.37 (1.11 – 1.69)  1.40 (0.86 – 2.29) 1.34 (0.81 – 2.23) 1.12 (0.64 – 1.95) 
Per 1 SD increase 1.26 (1.17 – 1.36) 1.23 (1.14 – 1.33) 1.15 (1.05 – 1.26)  1.20 (0.99 – 1.47) 1.19 (0.97 – 1.46) 1.12 (0.89 – 1.41) 
Waist to hip ratio        
Low 1.00 (Referent) 1.00 (Referent) 1.00 (Referent)  1.00 (Referent) 1.00 (Referent) 1.00 (Referent) 
Middle 1.84 (1.50 – 2.25) 1.81 (1.47 – 2.21) 1.73 (1.41 – 2.12)  0.98 (0.56 – 1.71) 0.99 (0.57 – 1.72) 0.97 (0.56 – 1.70) 
Upper 2.20 (1.80 – 2.69) 2.11 (1.72 – 2.58) 1.90 (1.54 – 2.36)  2.00 (1.23 – 3.24) 1.98 (1.21 – 3.24) 1.90 (1.16 – 3.12) 
Per 1 SD increase 1.29 (1.20 – 1.38) 1.26 (1.17 – 1.36) 1.20 (1.11 – 1.30)  1.13 (0.98 – 1.31) 1.13 (0.97 – 1.31) 1.12 (0.96 – 1.31) 
BAI indicates body adiposity index; BMI, body mass index; SD, standard deviation; %BF, percentage of body fat. 
a
 Adjusted for age, baseline examination year, and survey response pattern. 
b
 Adjusted for model 1 plus physical activity (active or inactive), smoking (current smoker or not), alcohol intake (> 14 drinks/week ♂ / > 7 
drinks/week ♀ or not), abnormal electrocardiogram, hypercholesterolemia and diabetes (present or not for each), and parental history of CVD 
and hypertension. 
c
 Adjusted for model 2 plus cardiorespiratory fitness (treadmill test duration in minutes). 
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Table 5. Baseline characteristics of participants who developed incident hypertension by sex. 
 
Males 
(n=765) 
Females 
(n=107) 
Total    
(n=872) P value
a
 
Age (years) 50.8 (9.6) 51.5 (9.9) 50.9 (9.7)  
Body mass index (kg/m2) 26.5 (3.3) 24.4 (4.5) 26.3 (3.6) <0.001 
Waist circumference (cm) 94.7 (9.3) 75.9 (11.0) 92.4 (11.3) <0.05 
Hip circumference (cm) 101.8 (6.9) 97.4 (10.2) 101.3 (7.5) <0.001 
BAI (%) 24.8 (3.0) 28.8 (4.9) 25.3 (3.5) <0.001 
%BF 21.9 (5.6) 27.5 (6.2) 22.6 (6.0)  
WHR 0.9 (0.1) 0.8 (0.1) 0.9 (0.1) <0.01 
Treadmill time (min) 18.8 (4.6) 13.3 (3.8) 18.1 (4.8) <0.05 
Maximal metabolic equivalents (MET) 12.0 (2.2) 9.5 (1.8) 11.7 (2.3) <0.01 
Total cholesterol (mg/dL) 207.4 (35.6) 200.9 (29.0) 206.6 (34.9) <0.05 
Fasting blood glucose (mg/dL) 100.3 (19.0) 99.0 (24.9) 100.1 (19.8)  
Blood pressure (mmHg)     
Systolic 122.2 (8.5) 120.5 (10.6) 122.0 (8.8) <0.01 
Diastolic 80.7 (5.8) 78.0 (7.0) 80.4 (6.0) <0.01 
Physically inactive, No (%)b 172 (22.5) 23 (21.5) 195 (22.4)  
Current smokers, No (%) 83 (10.8) 7 (6.5) 90 (10.3)  
Heavy drinkers, No (%)c 79 (10.3) 21 (19.6) 10 (11.5) <0.01 
Baseline medical conditions, No (%)     
Abnormal ECGd 88 (11.5) 15 (14.0) 103 (14.8)  
Hypercholesterolemiae 209 (23.7) 28 (26.2) 237 (27.2)  
Diabetes mellitusf 32 (4.2) 4 (3.7) 36 (4.1)  
Parental history of CVD, No (%) 161 (21.0) 33 (30.8) 194 (22.2) <0.05 
Parental history of hypertension, No (%) 170 (22.2) 50 (46.7) 220 (25.2) <0.001 
Values are means (standard deviations) or numbers (percentage). BAI indicates body adiposity 
index; %BF indicates percentage of body fat; WHR indicates waist to hip ratio; CVD, 
cardiovascular disease; MET: metabolic equivalents. 
a Analysis of the variance (ANOVA) for continuous variables and chi-square tests for categorical 
variables. 
b Defined as reporting no physical activity during leisure time in the 3 months before the 
examination. 
c Defined as >14 and >7 drinks/week for males and females, respectively. 
d Abnormal resting or exercise electrocardiogram. 
e Defined as total cholesterol ≥240 mg/dL or previous physician diagnosed hypercholesterolemia. 
f Defined as fasting blood glucose ≥126 mg/dL, previous physician diagnosed diabetes or use of 
insulin. 
 
 
 
